EUVIMEDEUVIMED entdecken
Systematische Übersicht

Epidemiology and burden of dengue fever in the United States: a systematic review

Lin H Chen, Carlos Marti, Clemente Diaz Perez, Bianca M Jackson, Alyssa M Simon, Mei Lu

Journal of Travel Medicine · 18.11.2023 · 30 (7)

DOI: 10.1093/jtm/taad127 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Travel Medicine, online erschienen am 04.10.2023. Verfasst von Lin H Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Travel Medicine, Mount Auburn Hospital, 330 Mount Auburn Street Suite 413 Cambridge, MA 02138, USA. Hauptthemen laut MEDLINE: Travel, Dengue. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 152 Literaturangaben. Gefördert von: Takeda Pharmaceuticals U.S.A., Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dengue is currently a global concern. The range of dengue vectors is expanding with climate change, yet United States of America (USA) studies on dengue epidemiology and burden are limited. This systematic review sought to characterize the epidemiology and disease burden of dengue within the USA.

Methods

Studies evaluating travel-related and endemic dengue in US states and territories were identified and qualitatively summarized. Commentaries and studies on ex-US cases were excluded. MEDLINE, Embase, Cochrane Library, Latin American and Caribbean Center of Health Sciences Information, Centre for Reviews and Dissemination and Clinicaltrials.gov were searched through January 2022.

Results

116 studies were included. In US states, dengue incidence was generally low, with spikes occurring in recent years in 2013–16 (0.17–0.31 cases/100,000) and peaking in 2019 (0.35 cases/100,000). Most cases (94%, n = 7895, 2010–21) were travel related. Dengue was more common in Puerto Rico (cumulative average: 200 cases/100,000, 1980–2015); in 2010–21, 99.9% of cases were locally acquired. There were <50 severe cases in US states (2010–17); fatal cases were even rarer. Severe cases in Puerto Rico peaked in 1998 (n = 173) and 2021 (n = 76). Besides lower income, risk factors in US states included having birds in residence, suggesting unspecified environmental characteristics favourable to dengue vectors. Commonly reported symptoms included fever, headache and rash; median disease duration was 3.5–11 days. Hospitalization rates increased following 2009 World Health Organization disease classification changes (pre-2009: 0–54%; post-2009: 14–75%); median length of stay was 2.7–8 days (Puerto Rico) and 2–3 days (US states). Hospitalization costs/case (2010 USD) were$14 350 (US states),$1764–$5497 (Puerto Rico) and$4207 (US Virgin Islands). In Puerto Rico, average days missed were 0.2–5.3 (work) and 2.5 (school).

Conclusions

Though dengue risk is ongoing, treatments are limited, and dengue's economic burden is high. There is an urgent need for additional preventive and therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TravelDengueUnited StatesHumansTravel-Related IllnessCaribbean RegionClimate Change

Stichwörter der Autor:innen

Dengueburden of diseaserisk factorssystematic review

Autor:innen und Institutionen

  • Division of Infectious Diseases and Travel Medicine, Mount Auburn Hospital, 330 Mount Auburn Street Suite 413 Cambridge, MA 02138, USA.
  • Associate Professor of Medicine, Harvard Medical School, 25 Shattuck Street Boston, MA 02115, USA.
  • Department of Pediatrics, San Juan City Hospital, Paseo Dr. Jose Celso Barbosa San Juan, PR 00921, Puerto Rico.
  • Department of Pediatrics, University of Puerto Rico School of Medicine, Medical Sciences Campus, San Juan, PR 00936, Puerto Rico.
  • Evidence & Access, OPEN Health, 25 Recreation Park Drive, Suite 200 Hingham, MA 02043, USA.
  • Takeda Pharmaceuticals U.S.A., Inc., 95 Hayden Avenue Lexington, MA 0242195, USA.

Förderung

  • Takeda Pharmaceuticals U.S.A., Inc

Zitieren

APA

Chen, L. H., Marti, C., Diaz Perez, C., Jackson, B. M., Simon, A. M., & Lu, M. (2023). Epidemiology and burden of dengue fever in the United States: a systematic review. Journal of Travel Medicine, 30(7). https://doi.org/10.1093/jtm/taad127

Vancouver

Chen LH, Marti C, Diaz Perez C, Jackson BM, Simon AM, Lu M. Epidemiology and burden of dengue fever in the United States: a systematic review. Journal of Travel Medicine. 2023;30(7). doi:10.1093/jtm/taad127

BibTeX
@article{Chen2023,
  author = {Chen, Lin H and Marti, Carlos and Diaz Perez, Clemente and Jackson, Bianca M and Simon, Alyssa M and Lu, Mei},
  title = {Epidemiology and burden of dengue fever in the United States: a systematic review},
  journal = {Journal of Travel Medicine},
  year = {2023},
  volume = {30},
  number = {7},
  doi = {10.1093/jtm/taad127}
}
Kostenlos starten →